Clinical Trials Browser

Phase 1 × capivasertib × Other hematologic neoplasm × Clear all

NCT04944771 2022-05-09

Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants

Phase 1 Completed

Other hematologic neoplasm

Hematologic Neoplasms